Precision Diabetes, Inc. (PDI) Presents Data on Precision IGT Prediabetes Test at Precision Diabetes Medicine 2021 Conference
Share this article Share this article RALEIGH, N.C., April 15, 2021 /PRNewswire/ -- Precision Diabetes, Inc. (PDI), an emerging leader in precision diabetes diagnostics, announced results today from a study on its Precision IGT prediabetes test at the Precision Diabetes Medicine 2021 Conference, the annual research symposium of the Precision Medicine in Diabetes Initiative (PMDI) -- a joint effort of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes...
United States North Carolina Jacqueline Madejczyk European Association For The Study Of Diabetes True Health Liquidating Trust Precision Medicine In Diabetes Initiative
Source: prnewswire.com